Epilepsy

Disease-a-month : DM
M C Smith, J M Buelow

Abstract

Diagnosis and management of the epilepsies are routinely performed by primary care physicians. In the United States, only 17% of patients with new-onset epilepsy are examined by neurologic specialists, and even fewer patients employ neurologists for their ongoing care. With the changes dictated by the evolving health care system in the United States, the responsibilities for the treatment of patients with epilepsies by primary care physicians will continue to increase. At the same time, there has been an explosion of new information about the diagnosis, evaluation, natural history, and neurobiologic aspects of epilepsy. New medical and surgical treatments are being introduced with a quickening pace. Finally, the concept that certain epilepsies may be progressive and that early identification and aggressive treatment represent one's best chance for establishing control for these patients has gained widespread confirmation from both clinical and animal model studies. The past standard of care is quickly ending. No longer should a patient or a physician accept only partial seizure control. This monograph attempts to lay the basis for improved understanding of epilepsy so that our patients will be seizure free without side effects ...Continue Reading

References

Sep 1, 1978·Neurology·R L Masland
Dec 1, 1975·Epilepsia·P J van der Lugt
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A E LehesjokiA de la Chapelle
Sep 1, 1991·Drugs·M C Smith, B J Riskin
Mar 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·R D ElwesP K Newman
Jan 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·R DuncanD J Wyper
Jan 1, 1989·British Journal of Clinical Pharmacology·B S Meldrum
Sep 1, 1989·Seminars in Neurology·M C SmithF Morrell
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·Y GeinismanL deToledo-Morrell
Jan 1, 1988·Acta Neurologica Scandinavica. Supplementum·H Silfvenius
Sep 1, 1986·Neurology·W A HauserV E Anderson
Sep 1, 1988·American Journal of Medical Genetics·D A GreenbergP I Terasaki
Oct 1, 1988·British Journal of Industrial Medicine·C John, D L McLellan
Nov 1, 1987·Disease-a-month : DM·T P Bleck
Apr 1, 1985·Archives of Neurology·F Morrell
Mar 1, 1985·Archives of Neurology·J R Hughes
Apr 1, 1985·The Journal of Experimental Medicine·S S PanterJ W Eaton
Oct 1, 1985·Annals of Neurology·P D WilliamsonR H Mattson
Jun 1, 1974·Epilepsia·J J Zieliński
Nov 1, 1969·Experimental Neurology·G V GoddardC K Leech
Jan 1, 1984·Annals of Neurology·A V Delgado-Escueta, D Greenberg
Apr 1, 1984·Epilepsia·C B DodrillB B Geary
May 7, 1981·The New England Journal of Medicine·R EmersonJ M Freeman

❮ Previous
Next ❯

Citations

Feb 1, 2022·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Geoffrey S YoungEllen J Bubrick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses
K Barry
Journal of the American Academy of Nurse Practitioners
Current Neurology and Neuroscience Reports
Carl W Bazil
© 2022 Meta ULC. All rights reserved